Document is current
Any future updates will be listed below
-
Authors
Papadimitriou, Nikos http://orcid.org/0000-0001-8294-7262
Bull, Caroline J.
Jenab, Mazda
Hughes, David J.
Bell, Joshua A.
Sanderson, Eleanor
Timpson, Nicholas J.
Smith, George Davey
Albanes, Demetrius
Campbell, Peter T.
Küry, Sébastien
Le Marchand, Loic
Ulrich, Cornelia M.
Visvanathan, Kala
Figueiredo, Jane C.
Newcomb, Polly A.
Pai, Rish K.
Peters, Ulrike
Tsilidis, Kostas K.
Boer, Jolanda M. A.
Vincent, Emma E.
Mariosa, Daniela
Gunter, Marc J.
Richardson, Tom G.
Murphy, Neil
-
Funding
Funding for this research was provided by:
Cancer Research UK (C18281/A29019, PPRCPJT\100005)
International Hundred K+ Cohorts Consortium / Global Genomic Medicine Collaborative ((IHCC/G2MC) No.31312020, (IHCC/G2MC) No.31312020)
World Cancer Research Fund (IIG_2019_2009)
UK MRC (MC_UU_00011/1)
Diabetes UK (17/0005587)
World Cancer Research Fund (IIG_2019_2009)
CRUK Integrative Cancer Epidemiology Programme (C18281/A29019)
Wellcome Trust (202802/Z/16/Z)
MRC & WT (217065/Z/19/Z)
University of Bristol NIHR Biomedical Research Centre (BRC-1215-20011)
MRC Integrative Epidemiology Unit (MC_UU_12013/3)
CRUK Integrative Cancer Epidemiology Programme (C18281/A19169)
UK Medical Research Council (MC_UU_00011/1)
University of Bristol
Medical Research Council Integrative Epidemiology Unit (MC_UU_00011/1, MC_UU_00011/1)
UKRI Innovation Research (MR/S003886/1)
- License Information
-
More Information
Article History
Received: 18 July 2022
Accepted: 9 December 2022
First Online: 4 January 2023
Declarations
:
: Ethics were approved by respective institutional review boards.
: Not applicable.
: Tom G Richardson is an employee of GlaxoSmithKline outside of the research presented in this manuscript. The remaining authors declare no competing interests.
